Glenmark Pharma

Glenmark Life Sciences: Nirma’s open supply and key insights on the inventory

by

Within the strategy of Nirma’s takeover of Glenmark Life Sciences (GLS) from its promoters Glenmark Pharma (GLP), an open supply to public shareholders can be constituted of February 15 to 29. With GLS buying and selling at ₹866 on February 13, owing to a turnaround in business state of affairs, the open supply value of … Read more

Solar Pharma, Zydus, Cipla, Torrent Pharma, Dr. Reddy’s: How Indian pharma is Gearing Up for M&A

by

Torrent Pharma and Dr.Reddy’s eyeing promoter stake in Cipla would possibly simply be the beginning of an acquisition spree within the pharma area. We consider Indian Pharma could now flex its monetary muscle for each large and small offers, with sectoral sentiments on a excessive, stability sheets robust and all enterprise segments gathering momentum. Firms … Read more